{
  "id": 198574,
  "name": "ALKERMES, INC.",
  "slug": "alkermes-inc",
  "state": "MA",
  "description": "&#226;€‹Pharmaceutical manufacturing and biopharmaceutical company.",
  "totalSpending": 1830000,
  "filings": 28,
  "yearlySpending": [
    {
      "year": 2019,
      "income": 50000
    },
    {
      "year": 2020,
      "income": 200000
    },
    {
      "year": 2021,
      "income": 300000
    },
    {
      "year": 2022,
      "income": 250000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 200000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "TODD STRATEGY GROUP"
  ],
  "lobbyists": [
    "DANIEL TODD",
    "PAUL EDATTEL",
    "JEFF LUCAS",
    "NICHOLAS UEHLECKE",
    "ERIC BERGREN",
    "KATHERINE COTTON",
    "TED LEHMAN",
    "TAYLOR SEXTON",
    "KIMBERLY LINTHICUM"
  ],
  "issues": [
    "PHA",
    "LAW",
    "BUD",
    "HCR",
    null
  ],
  "sampleDescriptions": [
    "Prescription drug pricing.",
    "Criminal justice bill introduction.",
    "Prescription drug pricing.\nC.R.8337: Continuing Appropriations Act, 2021.",
    "Appropriations related to SAMHSA grant services.",
    "Prescription drug pricing.\nH.R.5376 - Build Back Better Act.\nH.R.3684 - Infrastructure Investment and Jobs Act.",
    "Prescription drug pricing. H.R.5376 - Build Back Better Act.",
    "Prescription drug pricing. S.3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act. Awareness of outcomes data and the need for training on all medication assisted treatment. H.R.7667/S.4348 - Prescription Drug User Fee Agreement Reauthorization. H.R.5376 - Inflation Reduction Act of 2022.",
    "Prescription drug pricing. Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022.",
    "Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. Medicaid drug rebate program.",
    "Prescription drug pricing, including MDRP. Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. Medicaid drug rebate program."
  ],
  "years": [
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 380,
  "trajectory": "exploding",
  "yearsActive": 7,
  "avgAnnualSpending": 205714,
  "peakYear": 2021,
  "lobbyistCount": 9,
  "firmCount": 1,
  "issueCount": 4
}